465. Deputy Gillian Toole asked the Minister for Health if the HPRA (Health Product Regulatory Authority) warning system will be inspected and upgraded in light of findings from the Food and Drug Administration in the United States where warnings about adverse events relating to Messenger RNA Covid vaccines were not on alerts. [75302/26]
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
Showing questions asked by Gillian Toole .
28 questions match, newest first.
545. Deputy Gillian Toole asked the Minister for Health the incidence of shingles (varicella zoster), by age for each year 2015-2019 and 2021-2025, in tabular form. [69750/26]
556. Deputy Gillian Toole asked the Minister for Health the incidence of sepsis by age for each year 2015-2019 and 2021-2025, presented in tabular form. [69752/26]
560. Deputy Gillian Toole asked the Minister for Health the incidence of sudden adult death syndrome, by age in each of the years 2015-2019 and 2021-2025, in tabular form. [69751/26]
690. Deputy Gillian Toole asked the Minister for Health what examination is being carried out into the fourfold increase in neurological conditions since 2019, as referenced by the HSE Chief Clinical Officer, 22nd July 2026 at EU World Neurology Day. [68075/26]
698. Deputy Gillian Toole asked the Minister for Health the examination of the Health Products Regulatory Authority pharmacovigilance processes is being carried out in light of the recent British Medical Journal findings (September 16th 2026) of a faulty algorithm in the US Centre for Disease Control Vaccine Adverse Event Reporting System. [68072/26]
560. Deputy Gillian Toole asked the Minister for Health the differentiating factors between long-Covid and vaccine adverse events; the process of evaluation of differentiation is carried out, by data sources, public consultation and any other relevant metrics; and if she will make a statement on the matter. [54651/26]
713. Deputy Gillian Toole asked the Minister for Health the number of cases of conditions (details supplied) per annum from 2015 to 2019 and 2020 to 2025, in tabular form; and if she will make a statement on the matter. [52726/26]
253. Deputy Gillian Toole asked the Minister for Health the Departmental analysis of vitamin and mineral supplements that is being carried out to determine recommended daily amounts vis-à-vis the "typical" nutrition content of Irish diets, in advance of any European Union limit setting of nutrients; and if she will make a statement on the matter. [52320/26]
318. Deputy Gillian Toole asked the Minister for Health the timeline for the delivery of supports to patients with long-Covid and/or associated conditions; the analysis that has taken place to differentiate long-Covid from possible gene therapy adverse events; and if she will make a statement on the matter. [48338/26]
476. Deputy Gillian Toole asked the Minister for Health if information (details supplied) in relation to a series of matters regarding the policy, clinical and financial rationale for restricting access to long-acting injectable buprenorphine will be provided; and if she will make a statement on the matter. [33481/26]
553. Deputy Gillian Toole asked the Minister for Health the consideration and/or scoping of a health literacy initiative that is being undertaken to ensure better health outcomes for patients and enabling the future resourcing of novel drug therapies. [29476/26]
554. Deputy Gillian Toole asked the Minister for Health the reason drug companies are indemnified if vaccines are presented to the public as being safe and effective. [29477/26]
558. Deputy Gillian Toole asked the Minister for Health the reason drug companies indemnified are if vaccines are presented to the public as being safe and effective. [29492/26]
1662. Deputy Gillian Toole asked the Minister for Health the impact assessments which were carried out in 2020 when the developmental assessments of children, by public health nurses, were suspended during SARS Cov 2 and similarly, during the Health Service Executive pay & numbers strategies of 2022 and 2023; and if she will make a statement on the matter. [18268/26]
634. Deputy Gillian Toole asked the Minister for Health the contingency plan in place for the provision of general practitioner services in Ratoath and Dunboyne County Meath, pending the retirement of general practitioners from the provision of medical services in these towns, during the first quarter of 2026; and if she will make a statement on the matter. [16104/26]
440. Deputy Gillian Toole asked the Minister for Health the details of the indemnification of manufacturers of messenger RNA gene therapy supplied during the SARS Cov 2 pandemic; and if she will make a statement on the matter. [73256/25]
266. Deputy Gillian Toole asked the Minister for Health the examination and evaluation of the recently published Central Statistics Office figures for medical mortality that are taking place or scheduled to take place. [68408/25]
587. Deputy Gillian Toole asked the Minister for Health the retrospective cost-benefit analyses of State vaccination programmes carried out in order to determine each annual campaign; and if she will make a statement on the matter. [67252/25]
588. Deputy Gillian Toole asked the Minister for Health when a review of the rate of value added tax on oral vitamin and mineral supplements, currently 13.5% rate, will be carried out; and the reason there is a disparity in VAT classification between oral pharmaceuticals, and oral supplements for health promotion; and if she will make a statement on the matter. [67255/25]
484. Deputy Gillian Toole asked the Minister for Health the results of recruitment campaigns by the Health Service Executive and National Council for Special Education for healthcare professional roles (details supplied), in tabular form. [62588/25]
485. Deputy Gillian Toole asked the Minister for Health when a citizens' assembly on food will be convened, to ensure an all-of-Government approach to Irish food security and to meet the objectives of the Healthy Ireland policy and actions. [62592/25]
504. Deputy Gillian Toole asked the Minister for Health the status of the examination of a protected disclosure (details supplied) circulated to senior Cabinet members in July 2025 and asked as a Leader’s Questions on 22 October 2025; and if correspondences will be issued; and if she will make a statement on the matter. [62715/25]
393. Deputy Gillian Toole asked the Minister for Health who set the Terms of Reference for the Covid Evaluation Committee; the reason clinical and vaccination information is not being sought; the reason the 2020-2022 timeframe has been chosen; and if she will make a statement on the matter. [38643/25]
1599. Deputy Gillian Toole asked the Minister for Health the total number of women affected directly by the misreading of their cervical smear tests to date; and if she will make a statement on the matter. [30424/25]